Biophytis Announces 2021 Operational and Financial Results and Gives Updates on 2022 perspectives

Biophytis / Key word(s): Annual ResultsBiophytis Announces 2021 Operational and Financial Results and Gives Updates on 2022 perspectives 07-Apr-2022 / 08:00 CET/CESTBiophytis Announces 2021 Operational and Financial Results and Gives Updates on 2022 perspectives  Success of Nasdaq IPO in February 2021 €23.9M o...

Related Keywords

France ,Brazil ,New York ,United States ,Paris ,France General ,Massachusetts ,Belgium ,Veillet ,Rhôalpes ,Cambridge ,Cambridgeshire ,United Kingdom ,America ,French ,Brazilian ,American ,Biophytis Adss ,Evelyne Nguyen ,Agathe Boggio ,Jean Franchi ,Claude Allary ,Philippe Rousseau ,Atlas Negma ,Antoine Denry ,Rob Van Maanen ,Custom Development ,Data Monitoring Committee ,Manufacturing Organization ,Nasdaq ,Exchange Commission ,Development Expenses ,Company Board Of Directors On ,Access Program ,Annual Results ,Financial Results ,Gives Updates ,Euronext Growth Paris ,Kreos Capital ,Expanded Access Program ,Interim Analysis ,Per Protocol ,Minimal Clinically Important Difference ,Duchenne Muscular Dystrophy ,Benoit Canolle ,Chief Business Officer ,Chief Medical Officer ,Chief Financial Officer ,Independent Director ,Data Monitoring ,Emergency Use Authorization ,Conditional Marketing Authorization ,Intensive Care Unit ,Serious Adverse Events ,Nasdaq Capital Market ,Depositary Shares ,Bonds Redeemable ,Existing Shares ,Latin America ,Euronext Growth ,American Depositary Shares ,Year Report ,Financial Wire News ,